Results 201 to 210 of about 184,554 (278)

Lung and heart-lung transplantation in pulmonary arterial hypertension. [PDF]

open access: yesPLoS One, 2017
López-Meseguer M   +10 more
europepmc   +1 more source

Cell migration, chimerism, and graft acceptance [PDF]

open access: yes, 1992
A.J Demetris   +47 more
core   +1 more source

A contemporary simple risk score for prediction of severe acute kidney injury after heart transplantation

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1166-1175, April 2025.
A contemporary simple risk score for prediction of severe AKI after HT. Abstract Background The aim of this study was to develop a simple risk score to estimate severe acute kidney injury (AKI) risk based on a large contemporary heart transplantation (HT) cohort.
Shuangshuang Zhu   +10 more
wiley   +1 more source

Correction: Lung and heart-lung transplantation in pulmonary arterial hypertension. [PDF]

open access: yesPLoS One, 2018
López-Meseguer M   +10 more
europepmc   +1 more source

The two-way paradigm of transplantation immunology [PDF]

open access: yes, 1996
Demetris, AJ   +7 more
core   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo   +7 more
wiley   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant   +17 more
wiley   +1 more source

Spleen-derived classical monocytes mediate lung ischemia-reperfusion injury through IL-1β [PDF]

open access: yes, 2018
et al,   +14 more
core   +1 more source

Home - About - Disclaimer - Privacy